Remove Hospitals Remove Packaging Remove Research Laboratories
article thumbnail

MSD receives FDA approval for Enflonsia to prevent RSV

Pharmaceutical Technology

MSD research laboratories president Dean Li stated: “Enflonsia provides an important new preventive option to help protect healthy and at-risk infants born during or entering their first RSV season with the same dose regardless of weight. Give your business an edge with our leading industry insights.

FDA 52
article thumbnail

FDA to review MSD’s doravirine/islatravir NDA for HIV-1

Pharmaceutical Technology

MSD Research Laboratories global clinical development senior vice-president and head, chief medical officer Dr Eliav Barr stated: “MSD has been at the forefront of HIV research for more than 35 years and we are pleased to continue our work to innovate and deliver new options that aim to meet the needs of the HIV community.

FDA 52
article thumbnail

FDA approves MSD’s Keytruda to treat head and neck cancer

Pharmaceutical Technology

GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

FDA 52